SURYAPHARM

Mr. Dharam Pal Singhal, an Independent Director of the Company, resigned from the said office on June 15, 2013. The resignation of Mr. Dharam Pal Singhal was consequent to the resignations of Mr. Shiv Kumar Yadav (Independent Director) with effect from May 25, 2013 and Mr. Subhash Chander Marwaha (Nominee Director of SBI) with effect from May 29, 2013.As a result of the resignation of Mr. Dharam Pal Singhal, the total strength of the Board of Directors of the Company has reduced to two, which is less than the minimum number of Directors statutorily required for a public limited Company.The Boa

Surya Pharmaceutical Limited has informed the Exchange that consequent to the resignation of Mr. Bharat Bhushan Jain from the post of Chief Financial Officer & Company Secretary cum Compliance Officer of the Company with effect from May 28, 2013, the Company is in the process of appointing Company Secretary under the provisions of section 383A of the Companies Act, 1956, Till the time a Company Secretary is appointed, Sh. Rajiv Goyal, Chairman & Managing Director has been appointed as the Compliance Officer of the Company with effect from July 20, 2013 who shall liaison with the SEBI, Stock Ex

Surya Pharmaceutical Limited has informed the Exchange that Dr. R.K Gupta & Dr. H.B.L Vohra have resigned from the directorship of the Company.

Surya Pharmaceutical Limited has informed the Exchange that : (1) The Company has shifted its Registered Office from # 601, 6th Floor, Surya Kiran Building, 19, K.G Marg, Connaught Place, New Delhi - 110001 TO 1596 ,Floor 1st, Bhagirath Palace, Delhi with effect from April 27, 2012.(2) Dr. S.K.Yadav has been appointed as Additional Director of the company w.e.f. April 27, 2012..

Surya Pharmaceutical Limited has informed the Exchange that at the meeting of the Board of Directors of the Company held on November 12, 2011, Mr. Anil Arya & Mr. Abhishek Arya have resigned from the directorship of the Company w.e.f. November 12, 2011. The Board has appointed Mr. D.P. Singhal as Independent Additional Director of the Company.

Surya Pharmaceutical Limited has informed the Exchange that Mr. Rajansh Thukral has resigned from the post of Associate Director & Chief Company Secretary of the Company. In his place, Ms Sugandha Kukreja has joined as Company Secretary and she shall act as Compliance Officer of the Company.

Surya Pharmaceutical Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 31, 2009 has appointed Dr.H.B.L. Vohra and Mr.S.P.Sharma as Additional Directors on the Board of the Company in order to expand the Board by including Additional Independent Directors.

Surya Pharmaceutical Limited has informed the Exchange that "Sh. Sobhagya Mal Jain has resigned from the Directorship of the Company. His resignation has been accepted by the Board of Directors of the Company in their meeting held on October 22, 2007. In his place Sh. Abhishek Arya has been inducted as an Additional Director pursuant to section 260 of the Companies Act, 1956 to fill up the position of Independent Director in compliance with Clause 49 of the Listing Agreement".

Surya Pharmaceutical Limited has informed the Exchange that M/s. Bansal Mittal & Co., Chartered Accountants, the Statutory Auditiors of the company has submitted their resignation from the office of the Statutory Auditors of the company vide their letter dated August 03, 2006 due to their personal reasons. The Board of Directors, in their meeting held on August 05, 2006 has accepted the resignation and has proposed to appoint M/s. AAD & Associates SCO No. 371 373, IInd Floor, Sector 34-A, Chandigarh, Chartered Accountants, as the Statutory Auditors of the company.

Surya Pharmaceutical Limited has informed the Exchange that in Extra Ordinary General Meeting of the Company held on August 31, 2006, the shareholders have approved the appointment of M/s. AAD & Associates SCO No. 371-373, IInd Floor, Sector 34-A, Chandigarh, Chartered Accountants to fill up the vacancy arisen out of resignation of the earlier Statutory Auditors.

Surya Pharmaceutical Limited has informed the Exchange that following persons have resigned from the directorship of the company: 1. Mr. Uday Shantaram Karnik, Director-Marketing. 2. Mr. S.M. Singla, Director-Finance.